Krüppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells

• Published in: European heart journal Vol. 32; no. 3; pp. 371 - 377
• Main Authors: BOON, Reinier A, URBICH, Carmen, FISCHER, Ariane, FONTIJN, Ruud D, SEEGER, Florian H, KOYANAGI, Masamichi, HORREVOETS, Anton J. G, DIMMELER, Stefanie
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.02.2011
• Subjects: Animals; Biological and medical sciences; Cardiology. Vascular system; Cellular Senescence - physiology; Collateral Circulation - physiology; Coronary Artery Disease - physiopathology; Endothelial Cells - cytology; Endothelium, Vascular - cytology; Hindlimb - blood supply; Ischemia - physiopathology; Kruppel-Like Transcription Factors - metabolism; Leukocytes, Mononuclear - physiology; Medical sciences; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic - physiology; Stem Cells - cytology; Ischaemia; Cell therapy; Ageing; Cardiovascular disease; KLF2; Angiogenesis; Treatment; Ischemia; Capacity; Circulatory system; Neovascularization; Cardiology; Cell
• ISSN: 0195-668X; 1522-9645
• DOI: 10.1093/eurheartj/ehq137

Coronary artery disease (CAD) patients have less circulating proangiogenic cells (PACs), formerly known as endothelial progenitor cells, which exhibit impaired neovascularization properties. Inverse correlations were also found between PAC function and risk factors like age. Krüppel-like factor 2 (KLF2) is expressed by mature endothelial cells (ECs), is induced by both shear stress and statins, and provokes endothelial functional differentiation. The aim of this study is to identify whether KLF2 can reverse negative effects of ageing on PAC function. We describe that progenitor cells in the bone marrow and PACs also express KLF2 at a comparable level to mature ECs and that senescence decreases KLF2 levels. To study the effects of ageing on KLF2 levels, we compared progenitor cells of 4 weeks and 16- to 18-month-old C57BL/6 mice. In addition to the three-fold reduction of circulating Sca1(+)/c-Kit(+)/Lin(-) progenitor cells and the 15% reduction of Sca1(+)/Flk1(+) endothelial-committed progenitor cells, the spleen-derived PACs and bone marrow-derived progenitor cells isolated from aged mice showed a lower level of KLF2 when compared with young mice. Lentiviral overexpression of KLF2 increased human PAC numbers and endothelial nitric oxide synthase expression by 60% during in vitro culture. Endothelial lineage-specific KLF2 overexpression in aged bone marrow-derived mononuclear cells strongly augments neovascularization in vivo in a murine hind-limb ischaemia model. These results imply that KLF2 is an attractive novel target to rejuvenate PACs before autologous administration to CAD patients.